Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters











Database
Publication year range
1.
Virchows Arch ; 478(5): 961-968, 2021 May.
Article in English | MEDLINE | ID: mdl-33098490

ABSTRACT

Mycosis fungoides (MF) represents the most common type of cutaneous lymphoma. In the majority of patients, the disease has a slow evolution and a protracted course; however, a subset of patients shows poor oncologic outcomes. Unfortunately, there are no reliable prognostic markers for MF, and the currently available treatments are only effective in a minority of patients. This study aimed to evaluate the expression and clinical significance of PARP-1 and CAF-1/p60 in MF. Sixty-four MF representatives of the different stages of disease were assessed by immunohistochemistry for PARP-1 and CAF-1/p60. The association of PARP-1 and CAF-1/p60 with the MF stage and outcome was assessed by using Fisher's exact test and Kaplan-Meier survival analysis with the Log-rank test; a p value < 0.05 was considered significant. PARP-1 was overexpressed in 57.9% of MF and was significantly associated with a MF stage > II (p = 0.034) but not with the risk of death (p = 0.237). CAF-1/p60 was overexpressed in 26.8% of MF and was significantly associated with decreased overall survival (p < 0.001) but not with the MF stage (p = 1). A significant association was found between PARP-1 overexpression and CAF-1/p60 overexpression (p = 0.0025). Simultaneous overexpression of PARP-1 and CAF-1/p60 was significantly associated with decreased overall survival (p < 0.001), although less strongly than CAF-1/p60 alone (χ2 = 14.916 vs 21.729, respectively). In MF, PARP-1 is overexpressed in advanced stages, while CAF-1/p60 is overexpressed in the cases with shorter overall survival, appearing as a significant prognostic marker. A role for PARP-1 inhibitors and anti-CAF-1/p60 targeted therapy may be reasonably hypothesized in MF.


Subject(s)
Biomarkers, Tumor/analysis , Mycosis Fungoides/enzymology , Poly (ADP-Ribose) Polymerase-1/analysis , Skin Neoplasms/enzymology , Adult , Aged , Aged, 80 and over , Chromatin Assembly Factor-1/analysis , Female , Humans , Immunohistochemistry , Italy , Male , Middle Aged , Mycosis Fungoides/mortality , Mycosis Fungoides/pathology , Mycosis Fungoides/therapy , Neoplasm Staging , Predictive Value of Tests , Retrospective Studies , Risk Assessment , Risk Factors , Skin Neoplasms/mortality , Skin Neoplasms/pathology , Skin Neoplasms/therapy , Time Factors , Treatment Outcome
2.
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi ; 33(12): 1696-1701, 2017 Dec.
Article in Chinese | MEDLINE | ID: mdl-29382432

ABSTRACT

Objective To investigate the expressions of chromatin assembly factor 1 subunit A (CHAF1A) and proliferating cell nuclear antigen (PCNA) in cervical squamous cell carcinoma (CSCC) and their clinical implication. Methods Real-time quantitative PCR was performed to detect the mRNA levels of CHAF1A and PCNA in CSCC and corresponding paracancerous tissues. Immunohistochemistry was used to detect the expressions of CHAF1A and PCNA proteins in normal cervical epithelium tissues (NC), cervical intraepithelial neoplasia tissues (CIN), and CSCC. The correlation between CHAF1A and PCNA expressions and the relationship of the two proteins to the clinical pathological features of cervical cancer were analyzed. Results The expressions of CHAF1A and PCNA in CIN and CSCC were significantly higher than those in NC. In addition, CHAF1A and PCNA expressions were positively correlated in the CSCC tissues. Furthermore, overexpression of CHAF1A was significantly associated with the degree of differentiation, tumor size, depth of cancer invasion and HPV infection. Finally, the up-regulated expression of PCNA was correlated with the degree of differentiation, International Federation of Gynecology and Obstetrics (FIGO) grade, lymph node metastasis, depth of cancer invasion and HPV infection. Conclusion CHAF1A and PCNA are highly expressed in CSCC and associated with the malignancy.


Subject(s)
Carcinoma, Squamous Cell/pathology , Proliferating Cell Nuclear Antigen/analysis , Uterine Cervical Neoplasms/pathology , Adult , Aged , Cell Differentiation , Chromatin Assembly Factor-1/analysis , Chromatin Assembly Factor-1/genetics , Female , Humans , Lymphatic Metastasis , Middle Aged , Neoplasm Invasiveness , Proliferating Cell Nuclear Antigen/genetics
4.
PLoS One ; 8(9): e73332, 2013.
Article in English | MEDLINE | ID: mdl-24039914

ABSTRACT

BACKGROUND: Recent studies have highlighted the heterogeneity of gliomas and demonstrated that molecular and genetic analysis could help in their classification and in the design of treatment protocols. In a previous study we have identified a 4-gene signature highly correlated with survival of glioma patients. The aim of this study is to confirm and extend these findings by investigating the expression of these genes at the protein level and their association with outcome of patients with high grade gliomas. METHODOLOGY/PRINCIPAL FINDINGS: Immunohistochemical staining for EDN/RB, HJURP, p60/CAF-1 and PDLI4 was studied on archive materials from 96 patients (64 glioblastomas and 32 grade III gliomas). The levels of all four proteins differed significantly between grade III and grade IV tumours. The levels of the EDN/RB, HJURP and p60/CAF-1 proteins were strongly associated with overall survival (p<0.001, p<0.001 and p=0.002, respectively), whereas the one of PDLI4 was not (P=0.11). A risk criterion defined as high levels of at least two of the EDN/RB, HJURP and p60/CAF-1 proteins accurately predicted the prognosis of patients. Multivariate analysis confirmed that this criterion was an independent negative prognostic marker (hazard ratio = 2.225; 95% CI, 1.248 to 3.966, p=0.007). CONCLUSIONS: The expression of the EDN/RB, HJURP, p60/CAF-1 and PDLI4 proteins is disrupted in high grade gliomas and increases in the levels of these proteins are closely linked to tumour aggressiveness and poor outcome.


Subject(s)
Brain Neoplasms/diagnosis , Chromatin Assembly Factor-1/analysis , DNA-Binding Proteins/analysis , Glioblastoma/diagnosis , Glioma/diagnosis , LIM Domain Proteins/analysis , Receptors, Endothelin/analysis , Biomarkers, Tumor/analysis , Brain/metabolism , Brain/pathology , Brain Neoplasms/pathology , Gene Expression Regulation, Neoplastic , Glioblastoma/pathology , Glioma/pathology , Humans , Immunohistochemistry , Neoplasm Staging , Prognosis , Receptor, Endothelin B
5.
Cell Res ; 21(8): 1230-47, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21445097

ABSTRACT

Chromatin assembly factor 1 (CAF1) consisting of p150, p60 and p48 is known to assemble histones onto newly synthesized DNA and thus maintain the chromatin structure. Here, we show that CAF1 expression was induced in human cytomegalovirus (HCMV)-infected cells, concomitantly with global chromatin decondensation. This apparent conflict was thought to result, in part, from CAF1 mislocalization to compartments of HCMV DNA synthesis through binding of its largest subunit p150 to viral immediate-early protein 2 (IE2). p150 interaction with p60 and IE2 facilitated HCMV DNA synthesis. The IE2Q548R mutation, previously reported to result in impaired HCMV growth with unknown mechanism, disrupted IE2/p150 and IE2/histones association in our study. Moreover, IE2 interaction with histones partly depends on p150, and the HCMV-induced chromatin decondensation was reduced in cells ectopically expressing the p150 mutant defective in IE2 binding. These results not only indicate that CAF1 was hijacked by IE2 to facilitate the replication of the HCMV genome, suggesting chromatin assembly plays an important role in herpesviral DNA synthesis, but also provide a model of the virus-induced chromatin instability through CAF1.


Subject(s)
Chromatin Assembly Factor-1/metabolism , Cytomegalovirus/metabolism , Host-Pathogen Interactions , Immediate-Early Proteins/metabolism , Trans-Activators/metabolism , Amino Acid Substitution , Cell Line , Chromatin/metabolism , Chromatin Assembly Factor-1/analysis , Chromatin Assembly and Disassembly , DNA, Viral/metabolism , Histones/metabolism , Humans , Immediate-Early Proteins/analysis , Immediate-Early Proteins/genetics , Protein Binding , Protein Subunits/analysis , Protein Subunits/metabolism , Trans-Activators/analysis , Trans-Activators/genetics , Virus Replication
SELECTION OF CITATIONS
SEARCH DETAIL